CONSTITUENT REPORT
beta-Pinene
beta-Pinene is a common bicyclic monoterpene hydrocarbon found across conifer, citrus, and resin oils in the AromaForge archive, often contributing a fresh piney lift. Compared with many trace constituents, beta-pinene has a moderate research footprint: identity and occurrence are very strong, while biological evidence comes mainly from cell, fungal, and mouse studies plus broad reviews rather than human trials. The current source-grounded picture supports describing beta-pinene as a recurring aromatic constituent with preclinical antimicrobial, anti-biofilm, and mood-related research signals, while avoiding medical claims and noting that constituent-specific human efficacy and topical-limit data remain limited.
Chemical identity and composition
PubChem lists beta-pinene with molecular formula C10H16, a bicyclic monoterpene structure, and InChIKey WTARULDDTDQWMU-UHFFFAOYSA-N. In the archive it appears as both a major and minor constituent depending on oil type, ranging from dominant levels in galbanum and fir balsam to moderate levels in citrus peel and smaller amounts in resin oils.
Aroma and practical use
- Use the recorded piney, fresh, terpenic, green, resinous, resin descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
antimicrobial screening
An open-access Molecules paper evaluated alpha- and beta-pinene enantiomers against bacterial and fungal cells and reported antimicrobial and anti-biofilm activity, while also noting dose-related macrophage cytotoxicity at higher tested concentrations.
Measured: antimicrobial activity, biofilm inhibition, and cytotoxicity screening
This experimental finding does not establish benefit, dose or safety in people using this blend.
candida mode of action
A PubMed-listed abstract concluded that (+)-beta-pinene showed antifungal activity against Candida species, likely involving interference with the cell wall through molecular interaction with Delta-14-sterol reductase and to a lesser extent 1,3-beta-glucan synthase, while also reducing biofilm adhesion.
Measured: antifungal activity and proposed mechanism
This experimental finding does not establish benefit, dose or safety in people using this blend.
mouse monoaminergic signal
A PubMed-listed mouse study reported that beta-pinene produced an antidepressant-like effect and interpreted that signal as involving interaction with the monoaminergic system.
Measured: antidepressant-like activity with pathway interpretation
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
A review focused on turpentine and its major alpha- and beta-pinene fraction discusses human-health and toxicity considerations, but it is a broad review rather than a constituent-specific topical-use limit document.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific public IFRA leave-on limit or phototoxic restriction for isolated beta-pinene was located in the reviewed sources.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The accessible bioactivity literature for beta-pinene is largely preclinical, and at least one open screening paper also reported cytotoxicity at higher in-vitro test concentrations.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read 1,8-cineole report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →alpha-PineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Pinene report →MyrceneNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
traditional · effect
No source citation attached.
Read Myrcene report →gamma-TerpineneNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
traditional · effect
No source citation attached.
Read gamma-Terpinene report →How the effects were investigated
fungal cell wall and ergosterol pathway interference
Accessible antifungal literature on (+)-beta-pinene proposes interference with fungal cell-wall targets and docking interactions with Delta-14-sterol reductase, with some contribution from 1,3-beta-glucan synthase interaction.
This experimental finding does not establish benefit, dose or safety in people using this blend.
monoaminergic pathway interaction
A mouse antidepressant-style study reported that beta-pinene's behavioral signal was linked to interaction with the monoaminergic system rather than being framed as a direct clinical antidepressant effect.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No human clinical trials specific to isolated beta-pinene were located in the reviewed accessible sources.
- No constituent-specific public dermal-limit or phototoxicity threshold was located for isolated beta-pinene in this pass.
- Much of the positive literature is preclinical and may not translate directly to consumer topical or inhalation outcomes.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.